The historical rank and industry rank for TherapeuticsMD's Days Inventory or its related term are showing as below:
During the past 13 years, TherapeuticsMD's highest Days Inventory was 2080.92. The lowest was 77.01. And the median was 271.87.
TXMD's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.48 * Ranked among companies with meaningful Days Inventory only.
TherapeuticsMD's Days Inventory
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TherapeuticsMD's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.00.
TherapeuticsMD (NAS:TXMD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
TherapeuticsMD's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
TherapeuticsMD's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
TherapeuticsMD Days Inventory Related Terms
TherapeuticsMD Days Inventory Historical Data
* Premium members only.
The historical data trend for TherapeuticsMD's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TXMD vs CPHI, RMTI, AYTU: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, TherapeuticsMD's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TherapeuticsMD Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TherapeuticsMD's Days Inventory distribution charts can be found below:
* The bar in red indicates where TherapeuticsMD's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TherapeuticsMD (TXMD) has a Days Inventory of 0.00 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TherapeuticsMD and its competitors. Over the past decade, TherapeuticsMD's Days Inventory has ranged from 77.01 to 2,080.92. According to the industry distribution chart, TherapeuticsMD ranks #999999 out of 917 companies in the Drug Manufacturers industry.
Is TherapeuticsMD's Days Inventory too high?
TherapeuticsMD's current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 77.01 to a high of 2,080.92. Based on the distribution chart, TherapeuticsMD ranks #999999 out of 917 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, TherapeuticsMD has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TherapeuticsMD's Days Inventory compare to CPHI and RMTI?
According to the Drug Manufacturers industry distribution chart, TherapeuticsMD ranks #999999 out of 917 companies for Days Inventory. This places TherapeuticsMD in the lower half of its industry. The industry median Days Inventory is 164.48. Historically, TherapeuticsMD's own Days Inventory has ranged from 77.01 to 2,080.92 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on TherapeuticsMD and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TherapeuticsMD's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TherapeuticsMD stock overvalued right now?
Based on GuruFocus' analysis, TherapeuticsMD (TXMD) is currently considered Fairly Valued. The stock's GF Value™ is $2.06, compared to a current price of $2.26 — trading 9.7% above its estimated fair value. The current Days Inventory is 0.00. TherapeuticsMD's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For TherapeuticsMD (TXMD), the current Days Inventory is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TherapeuticsMD (TXMD) Overvalued in 2026?
Based on GuruFocus' analysis, TherapeuticsMD stock appears to be overvalued.
The current stock price of $2.26 is trading 9.7% above its estimated GF Value™ of $2.06.
GuruFocus considers TherapeuticsMD to be Fairly Valued.
Key valuation signals for TXMD:
Days Inventory: 0.00
GF Value™: $2.06 vs. price of $2.26 (9.7% above fair value)
No single metric tells the full story. See the TXMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
54GF Score
Get the complete analysis for TXMD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TXMD has been successfully added to your 
